Adipose dervied stem cell therapy(Ageless Biotech)

N/A

Report date: 2024/08/26 10:53:00

Base Information

Drug NameAdipose dervied stem cell therapy(Ageless Biotech)

Drug Alias NameOA-SYS

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adult stem cell therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAgeless Biotech Inc

China Registration ClassN/A

Develop Information

Active CompaniesAgeless Biotech Inc

Inactive CompaniesN/A

Active IndicationsOsteoarthritis, KneeOsteoarthritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A